Edison, Dainippon Sumitomo deal

Edison granted Dainippon exclusive rights to develop and commercialize EPI-743 and EPI-589 in Japan. Edison, which retains rights to the compounds outside of Japan, will receive $35 million up front and $15 million in R&D support from Dainippon. Edison is also eligible for $10-$35 million in development milestones per indication and up to $460 million in commercial milestones, plus royalties. ...